BPC-157 is ideal for adults experiencing: Muscle or ligament injuries Tendonitis, joint pain, or repetitive-stress injuries Chronic inflammation Gastrointestinal issues Post-operative recovery needs Slow healing or poor tissue repair High physical stress or demanding training Frequently used by athletes, weekend warriors, surgical patients, and longevity-focused individuals

WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
What exists is a growing body of preclinical data, early-phase human research, and a developing clinical consensus among peptide-prescribing physicians that points toward a relatively narrow therapeutic window
"Circadian regulation of NNMT expression and its role in metabolic homeostasis." Journal of Biological Rhythms, 36(4), 342-356
The 2024 Inflammopharmacology review compiled the most current GI-protection data set across more than two decades of research